NOVN Stock: Novan surges on patent Nitric Oxide Releasing CompositionsJay LorrenceJanuary 21, 2021Biotech Stocks, Featured Shares of Novan (NOVN) stock has surged 10% on the company getting granted patent on Nitric Oxide Releasing Compositions in Europe. This most likely is connecting to their inhalent drug for COVID-19. Jay Lorrence Investor of 12 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research. Articles: 233 Previous Post Greenlane Renewables (GRN) is a growth stock to look at Next Post President Biden signs executive order for expanding access to COVID-19 treatments Newsletter Updates Enter your email address below to subscribe to our newsletter I accept the Privacy Policy Subscribe